Respiratory Failure in a Patient with Exhaled Nitric Oxide >300 ppb and Subsequent Response to Dupilumab

Overview

Journal Proc (Bayl Univ Med Cent)

Specialty General Medicine

Date 2024 Dec 23

PMID 39712414

Authors

Howard Crisp

Affiliations

Soon will be listed here.

Abstract

Multiple biologic agents are approved for the treatment of severe persistent asthma not controlled by inhaled corticosteroid/beta-agonist therapy. Appropriate phenotyping can aid in picking the right biologic for the right patient. Here is a unique case of a patient with severe asthma and respiratory arrest, with fraction of exhaled nitric oxide >300 ppb whose asthma became completely controlled with dupilumab.

References

Pavord I, Deniz Y, Corren J, Casale T, FitzGerald J, Izuhara K . Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma. J Allergy Clin Immunol Pract. 2022; 11(4):1213-1220.e2. DOI: 10.1016/j.jaip.2022.11.043. View

Frossing L, Silberbrandt A, von Bulow A, Backer V, Porsbjerg C . The Prevalence of Subtypes of Type 2 Inflammation in an Unselected Population of Patients with Severe Asthma. J Allergy Clin Immunol Pract. 2020; 9(3):1267-1275. DOI: 10.1016/j.jaip.2020.09.051. View

Dweik R, Sorkness R, Wenzel S, Hammel J, Curran-Everett D, Comhair S . Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med. 2010; 181(10):1033-41. PMC: 2874447. DOI: 10.1164/rccm.200905-0695OC. View

Busse W, Kraft M, Rabe K, Deniz Y, Rowe P, Ruddy M . Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation. Eur Respir J. 2021; 58(2). PMC: 8339540. DOI: 10.1183/13993003.03393-2020. View

Loewenthal L, Menzies-Gow A . FeNO in Asthma. Semin Respir Crit Care Med. 2022; 43(5):635-645. DOI: 10.1055/s-0042-1743290. View

Busse W, Paggiaro P, Munoz X, Casale T, Castro M, Canonica G . Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma. Eur Respir J. 2021; 58(4). PMC: 8522685. DOI: 10.1183/13993003.04605-2020. View

Malinovschi A, Fonseca J, Jacinto T, Alving K, Janson C . Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects. J Allergy Clin Immunol. 2013; 132(4):821-7.e1-5. DOI: 10.1016/j.jaci.2013.06.007. View

Lehtimaki L, Csonka P, Makinen E, Isojarvi J, Hovi S, Ahovuo-Saloranta A . Predictive value of exhaled nitric oxide in the management of asthma: a systematic review. Eur Respir J. 2016; 48(3):706-14. DOI: 10.1183/13993003.00699-2016. View

Demoly P, Makatsori M, Casale T, Calderon M . The Potential Role of Allergen Immunotherapy in Stepping Down Asthma Treatment. J Allergy Clin Immunol Pract. 2017; 5(3):640-648. DOI: 10.1016/j.jaip.2016.11.024. View

10.

Corren J, Saini S, Gagnon R, Moss M, Sussman G, Jacobs J . Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial. J Asthma Allergy. 2021; 14:1045-1063. PMC: 8379710. DOI: 10.2147/JAA.S318892. View

11.

Zeiger R, Schatz M, Zhang F, Crawford W, Kaplan M, Roth R . Elevated exhaled nitric oxide is a clinical indicator of future uncontrolled asthma in asthmatic patients on inhaled corticosteroids. J Allergy Clin Immunol. 2011; 128(2):412-4. DOI: 10.1016/j.jaci.2011.06.008. View

12.

Malipiero G, Melone G, Puggioni F, Pawankar R, Heffler E, Paoletti G . Allergen immunotherapy and biologics in respiratory allergy: friends or foes?. Curr Opin Allergy Clin Immunol. 2020; 21(1):16-23. DOI: 10.1097/ACI.0000000000000707. View

13.

Diamant N, Amirav I, Armoni-Domany K, Sadot E, Shapira U, Cahal M . High fractional exhaled nitric oxide levels in asthma patients: Does size matter?. Pediatr Pulmonol. 2021; 56(6):1449-1454. DOI: 10.1002/ppul.25333. View

14.

Buhl R, Bel E, Bourdin A, Davila I, Douglass J, FitzGerald J . Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion. J Allergy Clin Immunol Pract. 2021; 10(2):422-432. DOI: 10.1016/j.jaip.2021.10.059. View